EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Anthracyclines-Induced Vascular Endothelial Dysfunction in Cancer Patients and Survivors Using Brachial Flow-Mediated Dilation (FMD) Tool: A Systematic Review and Meta-Analysis

Lana A Kattan iD, Sara M Abulola iD, Mohamed Izham Mohamed Ibrahim iD, Zaid H Maayah iD

Cardiovascular Toxicology · 2025

DOI: 10.1007/s12012-025-09986-2 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Cardiovascular Toxicology, 2025. Verfasst von Lana A Kattan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, 2713, Doha, Qatar. Hauptthemen laut MEDLINE: Anthracyclines, Brachial Artery, Vasodilation, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar University internal grant, Qatar University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anthracyclines are effective antineoplastic drugs; however, their use is constrained by dose-dependent cardiotoxicity. Vascular endothelial dysfunction is an early independent event in cardiovascular diseases and may precede anthracycline-induced cardiotoxicity. Brachial flow-mediated dilation (FMD) is a non-invasive technique for evaluating vascular endothelial function. We evaluated the evidence on anthracycline-induced vascular endothelial dysfunction in cancer patients and survivors using FMD. Studies measuring FMD in anthracycline-treated active cancer patients or survivors were retrieved from inception to August 2024 using PubMed, Embase, and Scopus. The primary outcome was the difference in FMD between anthracycline-treated patients and healthy controls or baseline. We performed the meta-analysis using a random-effects model and evaluated the certainty in effect estimates. Overall, 18 studies (n = 841 patients) met the inclusion criteria. Compared to the baseline, a non-significant change toward a decline in FMD was observed. However, a significant reduction in FMD was observed in anthracycline-treated patients compared to healthy controls (standardized mean difference (SMD): − 0.6082; 95% CI: − 0.8963 to − 0.3201; p < 0.0001). Subgroup analyses revealed consistent significant reductions in FMD for childhood cancers (SMD: − 0.7189; 95% CI: − 0.9903 to − 0.4476; p < 0.0001), while adult cancers showed no significant difference. No significant publication bias was detected overall for healthy control comparisons. High heterogeneity was observed in the included studies (I 2 = 81.7808% versus healthy controls and I 2 = 75.6876% for childhood cancers subgroup analysis). Anthracyclines induce vascular endothelial dysfunction, indicated by lower FMD in cancer patients and survivors, particularly among those with childhood cancers, who might be at risk of long-term cardiovascular complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnthracyclinesBrachial ArteryVasodilationNeoplasmsEndothelium, VascularCancer SurvivorsAntibiotics, AntineoplasticHumansCardiotoxicityFemaleMaleAdultPredictive Value of TestsRisk AssessmentMiddle AgedRisk FactorsAdolescentYoung Adult

Stichwörter der Autor:innen

AnthracyclineChildhood cancersEndothelial dysfunctionFlow-mediated dilation (FMD)

Substanzen

AnthracyclinesAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, 2713, Doha, Qatar.
  • Clinical Pharmacy and Practice Department, College of Pharmacy, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.
  • Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, 2713, Doha, Qatar. almaayah@qu.edu.qa.

ORCID-Profile: Lana A Kattan, Sara M Abulola, Mohamed Izham Mohamed Ibrahim, Zaid H Maayah

Förderung

  • Qatar University internal grant
  • Qatar University

Zitieren

APA

Kattan, L. A., Abulola, S. M., Mohamed Ibrahim, M. I., & Maayah, Z. H. (2025). Anthracyclines-Induced Vascular Endothelial Dysfunction in Cancer Patients and Survivors Using Brachial Flow-Mediated Dilation (FMD) Tool: A Systematic Review and Meta-Analysis. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-025-09986-2

Vancouver

Kattan LA, Abulola SM, Mohamed Ibrahim MI, Maayah ZH. Anthracyclines-Induced Vascular Endothelial Dysfunction in Cancer Patients and Survivors Using Brachial Flow-Mediated Dilation (FMD) Tool: A Systematic Review and Meta-Analysis. Cardiovascular Toxicology. 2025. doi:10.1007/s12012-025-09986-2

BibTeX
@article{Kattan2025,
  author = {Kattan, Lana A and Abulola, Sara M and Mohamed Ibrahim, Mohamed Izham and Maayah, Zaid H},
  title = {Anthracyclines-Induced Vascular Endothelial Dysfunction in Cancer Patients and Survivors Using Brachial Flow-Mediated Dilation (FMD) Tool: A Systematic Review and Meta-Analysis},
  journal = {Cardiovascular Toxicology},
  year = {2025},
  doi = {10.1007/s12012-025-09986-2}
}
Kostenlos starten →